{"id":309596,"date":"2019-12-12T19:16:06","date_gmt":"2019-12-13T03:16:06","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/12\/cstone-completes-registration-filing-for-the-phase-i-trial-cs3005\/"},"modified":"2019-12-12T19:16:22","modified_gmt":"2019-12-13T03:16:22","slug":"%e6%96%b0%e8%bf%9b%e5%b1%95%e5%9f%ba%e7%9f%b3%e8%8d%af%e4%b8%9a%e8%82%bf%e7%98%a4%e5%85%8d%e7%96%ab%e7%96%97%e6%b3%95-cs3005-%e4%bc%a0%e5%96%9c%e8%ae%af","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/12\/%e6%96%b0%e8%bf%9b%e5%b1%95%e5%9f%ba%e7%9f%b3%e8%8d%af%e4%b8%9a%e8%82%bf%e7%98%a4%e5%85%8d%e7%96%ab%e7%96%97%e6%b3%95-cs3005-%e4%bc%a0%e5%96%9c%e8%ae%af\/","title":{"rendered":"\u65b0\u8fdb\u5c55\uff01\u57fa\u77f3\u836f\u4e1a\u80bf\u7624\u514d\u75ab\u7597\u6cd5CS3005\u4f20\u559c\u8baf"},"content":{"rendered":"<p>\u57fa\u77f3\u836f\u4e1a\u4eca\u5929\u5ba3\u5e03\uff0c\u8be5\u516c\u53f8CS3005 \u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6700\u8fd1\u83b7\u5f97\u4e86\u6fb3\u5927\u5229\u4e9a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a\uff08HREC\uff09\u7684\u6279\u51c6\uff0c\u5e76\u83b7\u5f97\u4e86\u6fb3\u5927\u5229\u4e9a\u6cbb\u7597\u4ea7\u54c1\u7ba1\u7406\u5c40\uff08TGA\uff09\u7684\u8ba4\u53ef\u3002 CS3005\u662f\u4e00\u9879\u5f00\u653e\u6027\u3001\u591a\u4e2d\u5fc3\u3001\u5242\u91cf\u9012\u589e\u7684I\u671f\u7814\u7a76\uff0c\u65e8\u5728\u8bc4\u4f30CS3005\u5728\u665a\u671f\u5b9e\u4f53\u7624\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u3001\u836f\u4ee3\u52a8\u529b\u5b66\u53ca\u521d\u6b65\u6297\u80bf\u7624\u6d3b\u6027\u3002<\/p>\n<p>\u80bf\u7624\u5fae\u73af\u5883\uff08TME\uff09\u662f\u6307\u80bf\u7624\u7ec6\u80de\u6240\u5904\u7684\u5185\u5916\u73af\u5883\uff0c\u80bf\u7624\u5728\u5176\u4e2d\u4e0e\u5468\u56f4\u7684\u8840\u7ba1\u3001\u514d\u75ab\u7ec6\u80de\u3001\u57fa\u8d28\u6210\u5206\u53d1\u751f\u52a8\u6001\u7684\u76f8\u4e92\u4f5c\u7528\u3002\u7814\u7a76\u663e\u793a\uff0c\u80bf\u7624\u5fae\u73af\u5883\u4e2d\u5b58\u5728\u7684\u591a\u79cd\u4ee3\u507f\u6027\u514d\u75ab\u6291\u5236\u673a\u5236\u4e0d\u4ec5\u4e0e\u80bf\u7624\u7684\u53d1\u751f\u6709\u5173\uff0c\u8fd8\u5c06\u5f71\u54cd\u5bf9\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u7684\u54cd\u5e94\u7387\u3002\u5176\u4e2d\uff0c\u817a\u82f7\u4fe1\u53f7\u901a\u8def\u5c31\u5728\u673a\u4f53\u5185\u53d1\u6325\u91cd\u8981\u7684\u514d\u75ab\u8c03\u8282\u4f5c\u7528\uff0c\u662f\u5bf9\u4e8e\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u7684\u4e00\u79cd\u91cd\u8981\u4ee3\u507f\u6027\u62b5\u6297\u673a\u5236\u3002<\/p>\n<p>CS3005\u662f\u7531\u57fa\u77f3\u836f\u4e1a\u53d1\u73b0\u7684\u4e00\u79cd\u817a\u82f7A2a\u53d7\u4f53\u62ee\u6297\u5242\uff0c\u53ef\u8c03\u8282\u80bf\u7624\u514d\u75ab\u5fae\u73af\u5883\u3002 CS3005\u53ef\u80fd\u901a\u8fc7\u963b\u65ad\u817a\u82f7\u4e0e\u817a\u82f7A2a\u53d7\u4f53\u7684\u7ed3\u5408\u4ece\u800c\u9006\u8f6c\u514d\u75ab\u6291\u5236\u673a\u5236\uff0c\u4ece\u800c\u6f5c\u5728\u5730\u6fc0\u6d3b\u6297\u80bf\u7624\u514d\u75ab\u529b\u5e76\u6539\u5584\u5bf9\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u7684\u53cd\u5e94\u3002\u76ee\u524d\uff0c\u5168\u7403\u5c1a\u65e0\u6279\u51c6\u817a\u82f7A2a\u53d7\u4f53\u62ee\u6297\u5242\u7528\u4e8e\u764c\u75c7\u6cbb\u7597\u3002<\/p>\n<p>\u57fa\u77f3\u836f\u4e1a\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u6c5f\u5b81\u519b\u535a\u58eb\u8868\u793a\uff1a\u201c\u5f88\u9ad8\u5174\u770b\u5230CS3005\u7684\u4e34\u5e8a\u8bd5\u9a8c\u5728\u6fb3\u6d32\u83b7\u6279\uff0cCS3005\u662f\u516c\u53f8\u7b2c\u4e00\u6b3e\u5373\u5c06\u8fdb\u5165\u4e34\u5e8a\u8bd5\u9a8c\u9636\u6bb5\u7684\u80bf\u7624\u514d\u75ab\u5fae\u73af\u5883\u8c03\u8282\u5242\u3002\u8fd1\u5e74\u6765\uff0c\u514d\u75ab\u7597\u6cd5\u7ed9\u665a\u671f\u764c\u75c7\u75c5\u4eba\u5e26\u6765\u4e86\u66d9\u5149\uff0c\u9057\u61be\u7684\u662f\u76ee\u524d\u4ecd\u6709\u4f17\u591a\u60a3\u8005\u65e0\u6cd5\u5bf9\u5176\u4ea7\u751f\u5e94\u7b54\u3002\u6211\u4eec\u671f\u5f85\u901a\u8fc7\u5bf9\u80bf\u7624\u5fae\u73af\u5883\u8c03\u8282\u5242\u7684\u63a2\u7d22\u4e0e\u5f00\u53d1\uff0c\u80fd\u591f\u6269\u5927\u514d\u75ab\u6cbb\u7597\u7684\u83b7\u76ca\u4eba\u7fa4\u3002\u201d<\/p>\n<p>\u57fa\u77f3\u836f\u4e1a\u7684\u9996\u5e2d\u79d1\u5b66\u5b98\u738b\u8f9b\u4e2d\u535a\u58eb\u6307\u51fa\uff1a\u201c\u65e9\u671f\u5bf9\u817a\u82f7A2a\u53d7\u4f53\u62ee\u6297\u5242\u7684\u7814\u7a76\u663e\u793a\uff0c\u5bf9\u4e8e\u665a\u671f\u5b9e\u4f53\u7624\u60a3\u8005\uff0c\u65e0\u8bba\u662f\u5355\u4e00\u7597\u6cd5\u8fd8\u662f\u4e0e\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u8054\u5408\u4f7f\u7528\uff0c\u90fd\u5177\u6709\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u6297\u80bf\u7624\u6d3b\u6027\u3002\u5373\u4f7f\u662f\u5728PD-L1\u4f4e\u8868\u8fbe\uff0c\u6216\u8005\u5bf9PD-(L)1\u6291\u5236\u5242\u8010\u836f\u6216\u62b5\u6297\u7684\u60a3\u8005\u4e2d\uff0c\u817a\u82f7A2a\u53d7\u4f53\u62ee\u6297\u5242\u4e5f\u5177\u6709\u7597\u6548\uff0c\u8fd9\u9884\u793a\u7740\u5b83\u5c06\u6709\u53ef\u80fd\u8ba9\u591a\u79cd\u5b9e\u4f53\u7624\u60a3\u8005\u83b7\u76ca\u3002\u540c\u65f6CS3005\u4e5f\u8fdb\u4e00\u6b65\u62d3\u5c55\u4e86\u57fa\u77f3\u836f\u4e1a\u5728\u514d\u75ab\u7ec4\u5408\u6cbb\u7597\u7b56\u7565\u7684\u6df1\u5ea6\u548c\u7075\u6d3b\u6027\u3002\u201d<\/p>\n<p>\u57fa\u77f3\u836f\u4e1a\uff08HKEX\uff1a2616\uff09\u662f\u4e00\u5bb6\u751f\u7269\u5236\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u521b\u65b0\u7684\u514d\u75ab\u80bf\u7624\u5b66\u548c\u7cbe\u5bc6\u836f\u7269\uff0c\u4ee5\u6ee1\u8db3\u4e2d\u56fd\u548c\u5168\u7403\u764c\u75c7\u60a3\u8005\u672a\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\u3002 \u57fa\u77f3\u836f\u4e1a\u6210\u7acb\u4e8e2015\u5e74\uff0c\u5df2\u7ecf\u7ec4\u5efa\u4e86\u4e00\u652f\u4e00\u6d41\u7684\u7ba1\u7406\u56e2\u961f\uff0c\u5728\u521b\u65b0\u836f\u7269\u5f00\u53d1\u3001\u4e34\u5e8a\u7814\u7a76\u548c\u5546\u4e1a\u5316\u65b9\u9762\u62e5\u6709\u4e30\u5bcc\u7684\u7ecf\u9a8c\u3002<\/p>\n<p>\u82f1\u6587\u6765\u6e90\uff1aBiospace<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CStone Pharmaceuticals (&#8220;CStone&#8221; or the &#8220;Company&#8221;, HKEX: 2616) today announced that the Company has recently received the approval from the Human Research Ethics Committee (HREC) in Australia, and the acknowledgement from Australia&#8217;s Therapeutic Goods Administration (TGA) on the Phase I clinical trial of CS3005.<\/p>\n","protected":false},"author":9,"featured_media":309575,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,747,925,459],"class_list":["post-309596","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-747","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/309596","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=309596"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/309596\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/309575"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=309596"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=309596"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=309596"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}